SUMMARY
The spread of antibiotic-resistance genes in bacteria has severely reduced the efficacy of antibiotics, now contributing to 1.3 million deaths annually. Despite the far-reaching epidemiological implications of this trend, the extent to which antimicrobial resistance load varies within human populations and the drivers that contribute most to this variation remain unclear. Here, we demonstrate in a representative cohort of 7,095 Finnish adults1 that socio-demographic factors, lifestyle, and gut microbial community composition shape resistance selection and transmission processes. Antimicrobial resistance gene load was linked not only to prior use of antibiotics, as anticipated, but also to frequent consumption of fresh vegetables and poultry, two food groups previously reported to contain antibiotic-resistant bacteria. Interestingly, ARG load was not associated with high-fat and -sugar foods. Furthermore, antimicrobial resistance gene load was systematically higher in females and the generally healthier high-income demographics in urban and densely populated areas. Data from this prospective cohort with a 17-year follow-up suggests that the prognostic potential of antimicrobial resistome is comparable to blood pressure for mortality and sepsis. These findings highlight population-level risks and socio-demographic dimensions of antimicrobial resistance that are particularly relevant in the current context of global urbanization and middle-class growth.
Competing Interest Statement
R.K. is a scientific advisory board member and consultant for BiomeSense, Inc., has equity, and receives income. He is a scientific advisory board member and has equity in GenCirq. He is a consultant and scientific advisory board member for DayTwo and receives income. He has equity in and acts as a consultant for Cybele. He is a co-founder of Biota, Inc., and has equity. He is a cofounder of Micronoma and has equity and is a scientific advisory board member. The terms of these arrangements have been reviewed and approved by the University of California, San Diego, in accordance with its conflict of interest policies. Other authors declare no competing interests.
Funding Statement
KP, LL, VL, and GSK were supported by grants from the Research Council of Finland (decisions 348439 to KP; 330887 to LL and VL; 340314 to GSK) and the Alhopuro Foundation (decisions 20220114 to KP and 20210172 to GSK). CGV and GM are supported by an Australian National Health and Medical Research Council (NHMRC) grant GNT2013468. CSC IT Centre for Science computational resources were used for bioinformatic analysis of the samples.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study protocol of FINRISK 2002 was approved by the Coordinating Ethical Committee of the Helsinki and Uusimaa Hospital District (Ref. 558/E3/20 1 All participants signed informed consent. The study was conducted according to the World Medical Association's Declaration of Helsinki on ethical principles.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
